Harald Stummer

Prof. Harald Stummer

Department for Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL—Private University for Health Sciences, Medical Informatics and Technology, 6060 Hall in Tirol, Austria
+1
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2013 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
ENElisabeth Nöhammer
Elisabeth Nöhammer
Harald StummerHarald Stummer
Harald Stummer
CSClaudia Schusterschitz
Claudia Schusterschitz

1 October 2019 in American Journal of Health Economics
Verified
Journal Article
Closed access
SASilvia Angerer
Silvia Angerer
CWChristian Waibel
Christian Waibel
Harald StummerHarald Stummer
Harald Stummer
We employ a large-scale field experiment to investigate the impact of patients' socio-economic status on access to care. We request an appointment at more than 1,200 physicians in Austria varying the educational level of the patient. Our results show that overall patients with a university degree receive an appointment significantly more often than patients without a degree. Differentiating between practice assistants and physicians as responders, we find that physicians provide significantly shorter response times and marginally significant shorter waiting times for appointments for patients with than without university degree. Our results thus provide unambiguous evidence that discrimination by health providers contributes to the gradient in access to care. Furthermore, we argue that our results are consistent with implicit bias for practice assistants and statistical discrimination based on financial incentives for physicians.

17 November 2014 in Journal of Evidence-Based Complementary & Alternative Medicine
Verified
Journal Article
Open access
TRTobias Romeyke
Tobias Romeyke
Harald StummerHarald Stummer
Harald Stummer
The aim of this report is to provide the reader an overview of the complex therapy currently used within the German health system. Complex therapies in inpatient care in Germany establish the basis for an integrative and interdisciplinary provision of services. They define minimal criteria for the organization of a hospital, enable the integration of different therapeutic approaches, and therefore, lead to an intensive and holistic treatment by a specially trained team. The German model can be viewed as a pilot program for the introduction of integrative patient-centered care in other hospitals around the world.

29 June 2010 in International Journal of Workplace Health Management
Verified
Journal Article
Closed access
PDF file
ENElisabeth Nöhammer
Elisabeth Nöhammer
CSClaudia Schusterschitz
Claudia Schusterschitz
Harald StummerHarald Stummer
Harald Stummer
Purpose – The purpose of the present paper is to gain a first insight into the determinants of employee acceptance of, and participation in, workplace health promotion (WHP) in the German speaking part of Europe with a focus on Austria. Design/methodology/approach – Being a neglected field of research so far, a qualitative approach using problem-centred interviews was chosen. These were conducted with 19 employees in three different organizations, the four people there responsible for WHP as well as with nine health experts. These interviews form the basis for preliminary propositions. Findings – Determinants of employee acceptance of, and participation in, WHP are shown to concern information plus offer design. As for information, crucial factors are its flow, how it is presented and how it is received by the individual. Criteria regarding offer design are found on the individual and interpersonal level as well as referring to general environmental and organizational conditions. Research limitations/implications – Further research on a broad quantitative level is required to test the propositions developed on the basis of the present qualitative study. Practical implications – With their implications regarding information and offer design, the findings of the study can serve as a guideline for employee-centred WHP and are of interest to practitioners as well as academics in the field. Originality/value – Giving first insights into the employees' perspective regarding determinants of acceptance of, and participation in, WHP, this paper offers valuable suggestions for a target-group oriented design of WHP.

29 February 2012 in Global Journal of Health Science
Verified
Journal Article
Open access
PDF file
TRTobias Romeyke
Tobias Romeyke
Harald StummerHarald Stummer
Harald Stummer
Introduction : The distinctive characteristics of the German health system are medical progress and financial pressure—and this is especially true of the hospitals. These challenges must be met by strategic management instruments for quality assurance, and by reducing costs. Purpose : This article presents the instrument “clinical pathway” (also known as “clinical treatment pathway”) and describes the possibilities it offers, both for quality assurance and risk management, and for cost reduction. The clinical pathway presented here will be that for “multimodal pain therapy”, as used in the context of acute inpatient care in Germany. Methods : A general presentation of the risks in hospital is followed by consideration of the risks associated with core processes. A comprehensive total cost analysis is performed for those patients who meet the pathway entry criteria and who fulfil the requirements for the structure of care provided within multimodal pain therapy. Discussion and Conclusion : Multimodal pain therapy places high demands on the structural, procedural and outcome quality of the medical, nursing and therapeutic services provided, and these demands are reflected in high costs for the provision of this care. The treatment process involves many different professional groups. These complex interfaces can potentially generate risks, which can lead to the possibility of legal liability. A clinical pathway must structure the core process and then combine elements of quality assurance in order to optimise patient care and minimise risk. The examination of costs reveals significant potential savings (patients with clinical pathway: EUR 3086±212; patients without clinical pathway: EUR 3774±460; Mann-Whitney U test; p<0.001). For the managers of a hospital, the clinical pathway represents a strategic management instrument that can serve for continual cost control and cost reduction, and can contribute in the form of quality assurance towards a transparent provision of services.

31 July 2018 in Journal of Nursing Management
Verified
Journal Article
Closed access
PDF file
PSPetra Schadenhofer
Petra Schadenhofer
MKMichael Kundi
Michael Kundi
HAHeidemarie Abrahamian
Heidemarie Abrahamian
GBGerhard Blasche
Gerhard Blasche
Harald StummerHarald Stummer
Harald Stummer
Alexandra Kautzky-WillerAlexandra Kautzky-Willer
Alexandra Kautzky-Willer